Scarborough Advisors »

Capricor Therapeutics shares owned by Scarborough Advisors

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Scarborough Advisors from 13F filings

Historical chart of Scarborough Advisors investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Scarborough Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Scarborough Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0k 70 28.86

More positions owned by Scarborough Advisors

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Series Trust State Street Spd (SPYM)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Columbia Etf Tr I Resh Enhnc Cor (RECS)
Blackrock Etf Trust Ishares Us Thema (THRO)
Ishares Tr Msci Usa Mmentm (MTUM)
Invesco Exch Traded Fd Tr Ii Equal Wegt 0-30 (GOVI)
Blackrock Etf Trust Ishares A I Inno (BAI)
Spdr Gold Tr Gold Shs (GLD)
First Tr Exchange Traded Risng Divd Achiv (RDVY)

View all positions for Scarborough Advisors

Top funds holding Capricor Therapeutics

BlackRock
Susquehanna International
Vanguard Group
Point72 Asset Management
Suvretta Capital Management
Tang Capital Management
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
Darwin Global Management
Diadema Partners
Soleus Capital Management
J. Goldman & Co
Ikarian Capital

View all funds holding Capricor Therapeutics